This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.

Download Flyer

Twitter hashtag for this meeting: #KSnuclear

Nuclear Receptors and Friends: Roles in Energy Homeostasis and Metabolic Dysfunction (D3)

Scientific Organizers: Antonio J. Vidal-Puig, Antonio Moschetta and Anastasia Kralli

April 3—8, 2013

Alpbach Congress Centrum, Alpbach, Austria

Supported by the Directors' Fund

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

** Meeting has ended **
About Abstract Deadline
About Global Health Travel Award Deadline
About Scholarship Deadline
About Late Abstract Deadline
About Early Registration Deadline

Meeting Summary

This meeting brings fundamental cellular and physiological principles involving nuclear receptors and other transcription factors to the boundaries between physiology and disease oriented research. As evidenced by the session titles, the organizers have developed a program that covers the involvement of nuclear receptors (NR) and other transcription factors (TFs) regulating energy balance (food intake, energy expenditure and fat deposition), and their pathophysiological dysregulation leading to obesity associated cardiometabolic complications. The program has been configured to bring together diverse, sometimes conflicting ideas, and novel approaches to investigate the involvement of NR and TFs that may help to elucidate them. A primary goal is to gather junior and senior investigators who study transcriptional mechanisms controlling different aspects of energy homeostasis and metabolic adaptation, and thereby stimulate new ideas on how transcriptional networks could be targeted therapeutically in the context of metabolic disease. Taken together, the program design will provide an interdisciplinary integration of multiple organs and systems regulating energy homeostasis. Thus, this meeting is highly likely to attract a wide variety of investigators, many of whom might not otherwise interact.